Search
for
Sort by
Research 30 of 1000+
- Adverse events related to platelet-rich plasma therapy and future issues to be resolved
- Adverse Event Reporting in Clinical Trials of Finasteride for Androgenic Alopecia: A Meta-analysis.
- Adverse event reporting of four anti-Calcitonin gene-related peptide monoclonal antibodies for migraine prevention: a real-world study based on the FDA adverse event reporting system
- Adverse events of non-ablative fractional laser photothermolysis: a retrospective study of 856 treatments in 362 patients
- Adverse Events Associated with Azathioprine Treatment in Korean Pediatric Inflammatory Bowel Disease Patients
- Survey on adverse events associated with drug therapy for breast cancer patients
- Adverse Events in Isotretinoin Therapy: A Single-Arm Meta-Analysis
- Adverse events associated with vismodegib: insights from a real-world pharmacovigilance study using the FAERS database
- Adverse events in patients treated with Jak‐inhibitors for alopecia areata: A systematic review
- Adverse events associated with aromatase inhibitors: an analysis of real-world datasets and drug-gene interaction network
- Response to “The Role of Patient‐ and Drug‐Related Factors in Oral Minoxidil and Pericardial Effusion: Analyses of Data From the United States Food and Drug Administration Adverse Event Reporting System”
- Is the Safety of Finasteride Correlated With Its Route of Administration: Topical Versus Oral? A Pharmacovigilance Study With Data From the United States Food and Drug Administration Adverse Event Reporting System
- Adverse events of dual anti-seizure medication: Real-life data from a tertiary epilepsy clinic
- LSO-072 Comparison of COVID-19 vaccination with influenza vaccination in Korean patients with systemic lupus erythematosus: perception, adverse events, and flares from the CIVIL study
- EPH39 Alopecia Areata: Targeted Review of Adverse Events Associated with Clinical Studies of Treatments
- Adverse events of the thyroid peroxidase inhibitor methimazole in the treatment of hyperthyroidism: a comprehensive analysis from the first quarter of 2004 to the first quarter of 2025
- Safety Assessment of Ritlecitinib Based on the FDA Adverse Event Reporting System (FAERS) Database: A Real‐World Pharmacovigilance Study
- Adverse events with finasteride or dutasteride: FAERS
- (719) Signal Detection of Depression and Suicidality With the 5-Alpha Reductase Inhibitors: Evidence from the Food and Drug Administration (FDA) Adverse Event Reporting System (FAERS) Database
- A Gender Hypothesis of sex disparities in adverse drug events
- Association of Hair Loss With Suicidality and Psychological Adverse Events vs Finasteride Use—Reply
- Dermatological adverse events with taxane chemotherapy
- Dermatologic adverse events associated with afatinib: an oral ErbB family blocker
- Dupilumab‐associated cutaneous adverse events among adult patients with atopic dermatitis: A retrospective study
- Managing adverse events associated with vismodegib in the treatment of basal cell carcinoma
- Neuropsychiatric Adverse Events of Montelukast: An Analysis of Real-World Datasets and drug−gene Interaction Network
- Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
- Dermatologic adverse events in pediatric patients receiving targeted anticancer therapies: A pooled analysis
- Differences in reproductive toxicology between alopecia drugs: an analysis on adverse events among female and male cases
- The spectrum of cutaneous adverse events during encorafenib and binimetinib treatment in B‐rapidly accelerated fibrosarcoma‐mutated advanced melanoma